Skip to main content
SpringerLink
Log in

Locoregional Chemotherapy Including Perfusion

  • Chapter
Percutaneous Tumor Ablation in Medical Radiology

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

  • 1160 Accesses

Abstract

Regional chemotherapy is a form of anticancer therapy which has recently made striking advances. The rationale for regional application of cytotoxic agents is to increase local efficacy on one hand and to reduce systemic side-effects on the other hand. Regional administration of anticancer drugs may be recommended, if is known and if it is relatively localized and not disseminated. Many attempts have been made to increase the response by administering high concentrations of anticancer drugs selectively to the tumor tissue. It is advantageous for anticancer treatment if the toxic effects of the cytostatics on normal tissue are minimized by administering the drugs only to the cancer tissue in such a way that the drugs do not reach the normal tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aigner KR, Gailhofer S, Kopp S (1998) Regional versus systemic chemotherapy for advanced pancreatic cancer: a randomized study. Hepatogastroenterology 45:1125–1129

    PubMed  CAS  Google Scholar 

  • Alberts DS, Liu PY, Hannigan EV et al (1995) Phase III study of intraperitoneal (IP) cisplatin (CDDP) / intravenous (IV) cyclophosphamide (CPA) vs. IV CDDP/IV CPA in patients with optimal disease stage III ovarian cancer: a SWOG — GOG — ECOG Intergroup study (INT 0051). Proc Am Soc Clin Oncol 14:273

    Google Scholar 

  • Beger HG, Gansauge F, Buchler MW, Link KH (1999) Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis. World J Surg 23:946–949

    Article  PubMed  CAS  Google Scholar 

  • Benckhuijsen C, Kroon BB, van Geel AN et al (1988) Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics. Eur J Surg Oncol 14:157–163

    PubMed  CAS  Google Scholar 

  • Collins JM, Dedrick RL (1982) In: Chabner W (ed) Pharmacokinetics of anticancer drugs — pharmacologic principles of cancer treatment. Saunder, Philadelphia, pp 77–79

    Google Scholar 

  • Creech O, Krementz ET, Ryan RF et al (1958) Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148:616–632

    Article  PubMed  Google Scholar 

  • Deraco M, Gronchi A, Mazzaferro V et al (2002) Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with pseudomyxoma peritonei. Tumori 88(5):370–375

    PubMed  Google Scholar 

  • Harstrick A, Wilke H, Eberhardt W et al (1996) A phase I dose escalation trial of intravenous treosulfan in refractory cancer. Onkologie 19:153–156

    Article  Google Scholar 

  • Hilger RA, Harstrick A, Eberhardt W et al (1998) Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumours. Cancer Chemother Pharmacol 42:99–104

    Article  PubMed  CAS  Google Scholar 

  • Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S (1996) Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/ etoposide for Stage III non-small-cell lung cancer-a randomized study. J Clin Oncol 14:1065–1070

    PubMed  CAS  Google Scholar 

  • Klopp CT, Alford T, Bateman JB et al (1950) Fractionated intra-arterial cancer chemotherapy with methyl bis amine hydrochloride; a preliminary report. Ann Surg 132:811–832

    Article  PubMed  CAS  Google Scholar 

  • Lienard D, Ewaienko P, Delmotti JJ et al (1992) High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 10:52–60

    PubMed  CAS  Google Scholar 

  • Los G (2000) Intraperitoneal chemotherapy. In: Kerr DJ, Mc Ardle CS (eds) Regional chemotherapy — theory and practice. Harwood, Chur, pp 9–27

    Google Scholar 

  • Lygidakis NJ, Spentzouris N, Theodoracopoulos M et al (1998) Pancreatic resection for pancreatic carcinoma combined with neo-and adjuvant locoregional targeting immunochemotherapy — a prospective randomized study. Hepatogastroenterology 45(20):396–403

    PubMed  CAS  Google Scholar 

  • Markman M, Bundy BN, Alberts DS et al (2001) Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of Gynaecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol 19(4):1001–1007

    PubMed  CAS  Google Scholar 

  • Müller H (2002) Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer. Eur J Surg Oncol 28(2):165–171

    Article  PubMed  Google Scholar 

  • Ng B, Hochwald SN, Burt ME (1996) Isolated lung perfusion with doxorubicin reduces cardiac and host toxicities associated with systemic administration. Ann Thorac Surg 61:969–972

    Article  PubMed  CAS  Google Scholar 

  • Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Matsuoka H (2000) Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations. Chest 118(1):123–128

    Article  PubMed  CAS  Google Scholar 

  • Sadeghi B, Arvieux C, Glehen O et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88(2):358–363

    Article  PubMed  CAS  Google Scholar 

  • Stathopoulos GP, Dafni UG, Malamos NA, Rigatos S, Kouvatseas G, Moschopoulos N (1999) Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment. Anticancer Res 19(4C):3543–3548

    PubMed  CAS  Google Scholar 

  • Stehlin JS (1969) Hyperthermic perfusion with chemotherapy for cancers of the extremities. Surg Gynecol Obstet 129:305–308

    PubMed  Google Scholar 

  • Stephens FO (1983) Pharmacokinetics of intra-arterial chemotherapy. Vascular perfusion in cancer therapy. In: Schwemmle K, Aigner K (eds) Recent results in cancer research, vol. 86. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Sugarbaker PH (2001) Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 27(3):239–243

    Article  PubMed  CAS  Google Scholar 

  • Taguchi T (1979) Attainability of anticancer drugs into the tumour. Jpn J Cancer Clin 25:782–788

    CAS  Google Scholar 

  • Verwaal VJ, van Ruth S, de Bree E et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–3743

    Article  PubMed  Google Scholar 

  • Weissberger AS, Levine B, Stoorasli JP (1955) Use of nitrogen mustard in treatment of serious effusions of neoblastic origin. J Am Med Assoc 159:1704–1707

    Google Scholar 

Further Reading References

  • Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neoptolemos JP (2004) Current standards of surgery for pancreatic cancer [review]. Br J Surg 91(11):1410–1427

    Article  PubMed  CAS  Google Scholar 

  • Alexander HR, Fraker DL, Bartlett DL (1996) Isolated limb perfusion for malignant melanoma. Semin Surg Oncol 12:416–426

    Article  PubMed  Google Scholar 

  • Carmignani CP, Sugarbaker PH (2004) Comprehensive approach to advanced primary and recurrent ovarian cancer: a personal experience [review]. Expert Rev Anticancer Ther 4(3):477–487

    Article  PubMed  Google Scholar 

  • Cavanagh D, Hovadhanakul P, Comas MR (1975) Regional chemotherapy — a comparison of pelvic perfusion and intra-arterial infusion in patients with advanced gynecologic cancer. Am J Obstet Gynecol 123(4):435–441

    PubMed  CAS  Google Scholar 

  • Collins JM (1984) Pharmacological rational for regional drug delivery. J Clin Oncol 2(5):498–504

    PubMed  CAS  Google Scholar 

  • De Leyn P, Vansteenkiste J, Deneffe G et al (1999) Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: importance of pre-treatment mediastinoscopy. Eur J Cardiothorac Surg 15(5):608–614

    Article  PubMed  Google Scholar 

  • Dillman RO, Hemdon J, Seagren SL et al (1996) Improved survival in stage III nonsmall cell lung cancer. seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 88:1210–1215

    Article  PubMed  CAS  Google Scholar 

  • Eggermont AMM, Schraffordt-Koops H, Klausner JM et al (1996) Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft-tissue extremity sarcomas: the cumulative multicenter European experience. Ann Surg 224:756–765

    Article  PubMed  CAS  Google Scholar 

  • Feldman AL, Libutti SK, Pingpank JF et al (2003) Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 21:4560–4567

    Article  PubMed  CAS  Google Scholar 

  • Glehen O, Gilly FN, Sugarbaker PH (2003a) New perspectives in the management of colorectal cancer: what about peritoneal carcinomatosis? Scand J Surg 92:178–179

    PubMed  CAS  Google Scholar 

  • Glehen O, Mithieux F, Osinsky D et al (2003b) Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol 21:799–806

    Article  PubMed  CAS  Google Scholar 

  • Guadagni S, Aigner KR, Palumbo G et al (1998) Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer. J Clin Pharmacol 38(10):936–944

    PubMed  CAS  Google Scholar 

  • Guadagni S, Fiorentini G, Palumbo G et al (2001) Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer. Arch Surg 136(1):105–112

    Article  PubMed  CAS  Google Scholar 

  • Gutman M, Inbar M, Shlush-Lev D et al (1997) High dose tumor necrosis factor alpha and melphalan administered via isolated limb perfusion for advanced soft tissue sarcoma results in a > 90% response rate and limb preservation. Cancer 79:1129–1137

    Article  PubMed  CAS  Google Scholar 

  • Hendriks JM, Van Schil PE, Van Oosterom AA, Kuppen PJ, Van Marck E, Eyskens E (1999) Isolated lung perfusion with melphalan prolongs survival in a rat model of metastatic pulmonary adenocarcinoma. Eur Surg Res 31:267–271

    Article  PubMed  CAS  Google Scholar 

  • Kecmanovic DM, Pavlov MJ, Kovacevic PA et al (2003) Cytoreductive surgery for ovarian cancer. Eur J Surg Oncol 29(4):315–320

    Article  PubMed  CAS  Google Scholar 

  • Klein ES, Davidson B, Apter S, Azizi E, Ben-Ari GY (1994) Total abdominal perfusion (TAP) in the treatment of abdominal metastatic melanoma. J Surg Oncol 57(2):134–137

    Article  PubMed  CAS  Google Scholar 

  • Link KH, Leder G, Formentini A et al (1999) Surgery and multimodal treatments in pancreatic cancer — a review on the basis of future multimodal treatment concepts. Gan To Kagaku Ryoho 26(1):10–40

    PubMed  CAS  Google Scholar 

  • Lygidakis NJ, Sgourakis G, Aphinives P (1999) Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial. Hepatogastroenterology 46(27):2035–2038

    PubMed  CAS  Google Scholar 

  • Lygidakis NJ, Jain S, Sacchi M, Vrachnos P (2005) Adenocarcinoma of the pancreas — past, present and future [review]. Hepatogastroenterology 52(64):1281–1292

    PubMed  CAS  Google Scholar 

  • Müller H, Guadagni S (2001) Regional plus systemic chemotherapy: an effective treatment in recurrent non-small cell lung cancer. Eur J Surg Oncol 27(2):190–195

    Article  PubMed  Google Scholar 

  • Smeenk RM, Verwaal VJ, Zoetmulder FA (2006) Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei-a report of 103 procedures. Eur J Surg Oncol 32(2):186–190

    Article  PubMed  CAS  Google Scholar 

  • Sperti C, Pasquali C, Pastorelli D et al (2003) Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy [review]. Acta Biomed Ateneo Parmense 74[Suppl 2]:91–95

    Google Scholar 

  • Sugarbaker PH (1991) Early postoperative intraperitoneal adriamycin as an adjuvant treatment for advanced gastric cancer with lymph node or serosal invasion. In: Sugarbaker PH (ed) Management of gastric cancer. Kluwer, Boston, pp 277–284

    Google Scholar 

  • Sugarbaker PH (1999) Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43:S15–S25

    Article  PubMed  Google Scholar 

  • Sugarbaker PH (2003) Carcinomatosis — is cure an option? J Clin Oncol 21:762–764

    Article  PubMed  Google Scholar 

  • Sugarbaker PH, Welch LS, Mohamed F et al (2003a) A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 12:605–621

    Article  PubMed  Google Scholar 

  • Sugarbaker PH, Yu W, Yonemura Y (2003b) Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 21:233–248

    Article  PubMed  Google Scholar 

  • Vaglini M, Cascinelli F, Chiti A et al (1996) Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancer. Tumori 82(5):459–462

    PubMed  CAS  Google Scholar 

  • Vrouenraets BC, Klaase JM, Kroon BB et al (1995) Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions. Arch Surg 130:43–47

    PubMed  CAS  Google Scholar 

  • Wanebo HJ, Belliveau JF (1999) A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion. Cancer Chemother Pharmacol 43(5):427–434

    Article  PubMed  CAS  Google Scholar 

  • Wanebo HJ, Chung MA, Levy AI, Turk PS, Vezeridis MP, Belliveau JF (1996) Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloonocclusion technique. Ann Surg Oncol 3(3):295–303

    Article  PubMed  CAS  Google Scholar 

  • Wieberdinck K, Benckhuijsen C, Braat RP et al (1982) Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol 18:905–910

    Article  Google Scholar 

  • Yonemura Y, Bandou E, Kinoshita K, Kawamura T, Takahashi S, Endou Y, Sasaki T. (2003) Effective therapy for peritoneal dissemination in gastric cancer. Surg Oncol Clin N Am 12:635–648

    Article  PubMed  Google Scholar 

  • Zanon C, Clara R, Chiappino I et al (2004) Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg 28(10):1040–1045

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oncological Surgery, Hammelburg Hospitals, Ofenthaler Weg 20, 97762, Hammelburg, Germany

    Herwart Müller MD

Authors
  1. Herwart Müller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute for Diagnostic and Interventional Radiology University Hospital, Johann Wolfgang Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany

    Thomas J. Vogl MD (Professor) & Martin G. Mack MD (PD) (Professor) &  (PD)

  2. Department of Diagnostic and Interventional Radiology and Nuclear Medicine Klinikum Bogenhausen, Academic Teaching, Hospital of the Technical University Munich, Engelschalkingerstrasse 77, 81925, Munich, Germany

    Thomas K. Helmberger MD (Professor) (Professor)

  3. Department of Clinical Radiology University Hospitals — Grosshadern and Innenstadt, Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 81377, Munich, Germany

    Maximilian F. Reiser MD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Müller, H. (2008). Locoregional Chemotherapy Including Perfusion. In: Vogl, T.J., Helmberger, T.K., Mack, M.G., Reiser, M.F. (eds) Percutaneous Tumor Ablation in Medical Radiology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68250-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68250-9_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22518-8

  • Online ISBN: 978-3-540-68250-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation